Skip to main content
. 2017 Sep 29;12(9):e0185529. doi: 10.1371/journal.pone.0185529

Table 1. Genotypic and allelic frequencies of rs13140012, rs6553010, and rs2119882 in the melatonin receptor type 1A gene.

Polymorphism Controln (%) GDn (%) HTn (%) AITDn (%) OR1 (95% CI) OR2 (95% CI) OR3 (95% CI)
rs6553010
AA 159 (45.3) 162 (50.9) 30 (36.1) 192 (47.8) 1 1 1
AG 149 (42.5) 120 (31.7) 39 (47.0) 159 (39.7) 0.79 (0.57~1.09) 1.39 (0.82~2.35) 0.83 (0.65~1.20)
GG 43 (12.3) 36 (11.3) 14 (16.9) 50 (12.5) 0.82 (0.50~1.35) 2.34 (0.24~22.7) 0.96 (0.61~1.52)
AG+GG 192 (54.8) 156 (43.0) 53 (63.9) 209 (52.2) 0.80 (0.59~1.08) 1.46 (0.89~2.40) 0.90 (0.68~1.20)
Allele
A 467 (66.5) 444 (69.8) 99 (60.7) 543 (67.7) 1 1 1
G 235 (33.5) 192 (30.2) 67 (39.3) 259 (32.3) 0.86 (0.68~1.08) 1.35 (0.95~1.90) 0.95 (0.76~1.18)
rs13140012
AA 140 (39.9) 149 (46.9) 26 (31.3) 175 (43.6) 1 1 1
AT 165 (47.0) 136 (42.8) 46 (55.4) 182 (45.4) 0.77 (0.56~1.07) 1.50 (0.88~2.55) 0.88 (0.65~1.20)
TT 46 (13.1) 33 (10.4) 11 (13.3) 44 (11.0) 0.67 (0.41~1.12) 1.29 (0.59~1.81) 0.73 (0.46~1.17)
AT+TT 201 (60.1) 169 (53.2) 57 (68.7) 216 (56.4) 0.75 (0.55~1.02) 1.46 (0.87~2.42) 0.85 (0.64~1.14)
Allele
A 445 (63.4) 434 (68.2) 98 (59.0) 532 (66.3) 1 1 1
T 257 (36.6) 202 (31.8) 68 (41.0) 270 (33.7) 0.81 (0.64~1.01) 1.20 (0.85~1.70) 0.87 (0.70~1.07)
rs2119882
TT 140 (39.9) 153 (48.1) 28 (33.7) 181 (45.1) 1 1 1
CT 166 (47.3) 132 (41.5) 43 (51.8) 175 (43.6) 0.73 (0.53~1.01) 1.30 (0.77~2.19) 0.82 (0.60~1.11)
CC 45 (12.8) 33 (10.4) 12 (14.5) 45 (11.2) 0.67 (0.41~1.11) 1.33 (0.63~2.84) 0.77 (0.48~1.24)
CC+CT 211 (60.1) 165 (51.9) 55 (66.3) 220 (54.8) 0.72(0.53~0.97* 1.30 (0.79~2.76) 0.81 (0.60~1.08)
Allele
T 446 (63.5) 438 (68.9) 99 (60.7) 537 (67.0) 1 1 1
C 256 (36.5) 198 (31.1) 67 (39.3) 265 (33.0) 0.79(0.63~0.99* 1.18 (0.83~1.67) 0.86 (0.70~1.06)

GD, Graves’ disease; HT, Hashimoto’s thyroiditis; AITD, autoimmune thyroid disease (GD + HT); control, control group. OR1, odds ratio 1, GD vs. the control; OR2, odds ratio 2, HT vs. the control; OR3, odds ratio 3, AITD vs. the control; CI, confidence interval

* p<0.05.